
B. Riley Securities Reaffirms Their Buy Rating on LifeMD (LFMD)

I'm PortAI, I can summarize articles.
B. Riley Securities has reiterated its Buy rating on LifeMD with a price target of $10.00. Additionally, Lake Street's Ryan Meyers also issued a Buy rating, while TR | OpenAI maintained a Hold rating on LifeMD.
In a report released today, from B. Riley Securities reiterated a Buy rating on LifeMD, with a price target of $10.00.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
In addition to B. Riley Securities, LifeMD also received a Buy from Lake Street’s Ryan Meyers in a report issued today. However, on November 14, TR | OpenAI – 4o reiterated a Hold rating on LifeMD (NASDAQ: LFMD).

